The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

Taiwanese scientists have discovered a new way to synthesize circular RNA (circRNA), which could be applied to vaccine ...

More than 2.7 million confirmed national cases of Covid-19 have been logged since our very first was announced on February 28 ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Robert F Kennedy Jr has issued a 90-day pause for a $200million Biden-era contract with Vaxart Inc to develop a new oral ...

A new type of mRNA vaccine, added to standard cancer treatment, could help some patients with pancreatic cancer live longer.

Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd. (a joint stock company incorporated in the People's Republic of China with limited liability) (Stock Code: 6660.HK) ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...